← Back to Clinical Trials
Recruiting NCT05673915

Study of Transcranial Direct Current Stimulation to Treat Epilepsy

Trial Parameters

Condition Focal Epilepsy
Sponsor Mayo Clinic
Study Type INTERVENTIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 6 Years
Max Age N/A
Start Date 2023-04-12
Completion 2026-12
Interventions
ActivaDose II 0.1 mA transcranial direct current stimulation (tDCS)ActivaDose II 2.0 mA transcranial direct current stimulation (tDCS)

Brief Summary

The purpose of this research is to see to what extent electrical stimulation applied to the scalp (transcranial direct current stimulation or tDCS) can reduce the number and intensity of epileptic seizures.

Eligibility Criteria

Inclusion Criteria * Clinical diagnosis of generalized onset or focal epilepsy or sleep-related epileptic encephalopathy. * Estimated to have at least 2 countable seizures per month or spike-wave index ≥50%. * Has not had control with at least 2 anti-seizure medicines. * Able to maintain a constant medication for duration of the study (rescue meds allowed). * Subject or legally authorized representative is able to understand consent and keep a seizure diary in English. Exclusion Criteria: * A disease likely to progress over course of the study. * Psychogenic non-epileptic seizures. * Suicide attempt or psychiatric hospitalization past 2 years. * A skin condition interfering with scalp electrodes or allergy to silver. * Women will verify not pregnant, and if applicable, have a serum pregnancy test. * Implanted devices (e.g. pacemakers)-except VNS, which is allowed.

Related Trials